AxisWire Archives - Green Market Report

AxisWireOctober 18, 2021

5min860

Chicago, Illinois, October 18, 2021 –– RSX Enterprises, Inc. d/b/a Cultivation Design Build (www.cultivationdesignbuild.com), a sales and marketing firm serving the controlled agricultural environment (CEA) market, announced its new grow facility solution in partnership with Sprung Structures (www.sprung.com) and Porta-King Grow Rooms (www.portaking.com).  This innovative, cutting-edge solution can deliver a completed exterior and interior structure at least 12 weeks faster than conventional construction, even without factoring in significant labor and commodity supply constraints currently impacting conventional construction projects.

To find RSX at MJBizCon, visit Sprung booth C8723 or Porta-King booth C8722.

Using our tension membrane and modular wall facility, with large in stock inventory, fast delivery and lowered installation times, a grower with 5,000 feet of plant canopy not only can get a head start on other newly licensed growers, but can generate almost $2.1 million in additional crop revenue, based on a dried flower yield of 65 grams per canopy square foot and a $2,000 wholesale price per pound of flower, both reasonable goals. Plus, our solution ensures that the grower meets any state-mandated post-licensure deadline to begin growing operations.

Speed to first harvest can also help growers with their product marketing and sales efforts as they can quickly gear up to meet needs within their market. Early market entry can mean higher wholesale prices and a quicker path to brand and customer loyalty, especially in markets that promote craft cultivation – such as IL, MI, NJ, and NY – where product consistency and quality become defining factors in cultivation success. Craft growers that can become first-to-market operators are also better positioned for highly profitable early exits via acquisition by larger multi-state operators.

Tension membrane buildings are more scalable and relocatable compared to conventional construction methods – giving growers the option to add space later or when regulations change or simply to achieve a phased building plan to meet budget requirements. Sprung structures also can withstand extreme climates (cold, seismic, fire resistance, hurricane rated) and carry 25-year guarantee on the blackout membrane for indoor facilities.  Cleanliness and biosecurity are both better with modular construction techniques.

Our superior and cost-efficient environmental control system is anchored by our new line of Neocision Spectra high-performance LED lights that are manufactured by BVV, a leading extraction and processing equipment manufacturer, which are independently tested by third party laboratories at a PPF efficacy of 2.85 μmols/J at 240 VAC and carry an industry leading 7-year warranty.

About RSX Enterprises, Inc.

RSX’s principals have provided lighting and facility design-build solutions for more than 500,000 square feet of indoor cultivation facilities over the past two years, including retrofits and new construction for commercial and craft growers. RSX’s service-oriented sales approach includes: (i) assessing existing facility concepts and financial budgets to define project objectives and timelines, (ii) preparing lighting and facility layouts which are used to develop systems requirements, (iii) advising on engineering design-build and equipment specifications, coordinating supply chain issues, and facilitating project management and troubleshooting, and (iv) coordinating equipment and systems procurement, timely delivery and vendor-provided commissioning.  RSX’s value-added proposition:  assist cultivators to effectively implement their capital programs, improve time to first harvest, lower operating costs, and increase yields and product consistency.

For more information, please contact:

RSX Enterprises, Inc.
Randy Shipley, President
randy@rsxenterprises.com
(312) 446-4678


StaffApril 9, 2021
bellamyXtrulieveXMD-copy.jpg?fit=850%2C531&ssl=1

3min1071

FRANKLIN SQUARE, NY -April 9, 2021 /AxisWire/ With the 50th anniversary of ‘420’ just around the corner, Trulieve, Florida’s largest chain of medical marijuana treatment centers, is celebrating one year of collaboration with celebrity country music band “The Bellamy Brothers.”

In 2020, Trulieve created a new brand called the “Old Hippie Stash.” The Bellamy Brothers David and Howard hand selected attributes for three stains of medical cannabis.

The three strains of medical marijuana available only at Trulieve are “Reggae Cowboy,” “Afterglow,” and “Big Love.” The Reggae Cowboy and Big Love strains are Sativa hybrids, while Afterglow is a straight Indica to promote relaxation and can help with pain relief.

Valda Coryat, Trulieve’s Chief Marketing Officer, along with David and Howard Bellamy (The Bellamy Brothers) were interviewed by Lori Reese of MarijuanaDoctors.com via Zoom. The live interview shares a candid discussion that fans will want to hear. From life on the “Honky Tonk Ranch” to the changing role of medical cannabis as an alternative medicine. The award-winning musical duo also talks about the country music talents that were lost due to COVID-19, and their songs about the pandemic, including “Rednecks Looking for Paychecks” and “No Country Music for Old Men.” A tribute to Kenny Rogers, Charlie Pride, and other legendary country crooners.

The one-year anniversary of the “Old Hippie Stash” is April 9th. The Bellamy Brothers and Trulieve are celebrating by giving away 15 gift boxes for fans. Participants (USA only and 21-years of age and older) can enter on the MarijuanaDoctors.com blog post about the interview: https://www.marijuanadoctors.com/blog/bellamy-brothers-1st-anniversary-interview/

Winners will be randomly selected and announced by MarijuanaDoctors.com on Facebook, on Monday April 12th.

—————————————-

MarijuanaDoctors.com is America’s original online resource for medical cannabis information — Since 2010! Patients who want to get their medical card can find practitioners in each of the thirty-six states where medical marijuana is legal. Find a doctor & get your card. Learn if telemedicine medical card health evaluations are available in your state, at MarijuanaDoctors.com.

Contact:

Vincent B. Donadio

Marketing Director

Marijuana Doctors

donadio@marijuanadoctors.com

(516) 217-2712


AxisWireMarch 18, 2021
Screen-Shot-2021-03-18-at-10.39.44-AM.png?fit=960%2C463&ssl=1

4min1650

Keynote by Barrington Rutherford, SVP of Real Estate and Community Integration at Cresco Labs
CEs and CLEs Credit Certifications Available 

March 17, 2021 – New York – Mannada Events, a minority woman-owned cannabis professional education event production company based in New York City, will host its first Cannabis Real Estate Summit (“CRES”) on April 8, 2021, from 9:00 a.m. – 2:00 p.m. EST. 

The conference kicks off with a welcome from Chante Harris, SVP at Capalino & Company, and includes a keynote by Barrington Rutherford, SVP of Real Estate and Community Integration at Cresco Labs. Additionally, through specific program sessions, continuing education (CE) and continuing legal education (CLE) credits are available.

In a 2018 survey by Denver-based PropTech developer Apto, 76 percent of commercial real estate brokers handling cannabis deals in all states where it is legal in some form reported cannabis deals pricing above the market.

“Real estate is the backbone of the cannabis industry – you can’t obtain a legal license without securing a real estate location for your application,” said Mannada Founder and real estate attorney Kristin Jordan. “We want attendees to walk away with a better understanding of the massive opportunity in cannabis real estate and a roadmap of how to navigate the retail side of this nascent industry.”

The reality is that while a massive opportunity, real estate continues to remain a challenge for operators, with limited real estate availability, little to no federal banking for mortgages and fractured regulations from one state to the next.

“While some see real estate as boring, in the cannabis industry, it’s anything but,” said Barrington Rutherford, SVP of real estate and community integration at Cresco Labs. “There are huge opportunities in cannabis real estate for professionals who want to make the jump. There’s a considerable need for lawyers, engineers, designers and real estate intelligence needed in new legal cannabis markets.”

CRES is part of Mannada’s Cannabis Summit Series. Mannada also produces the weekly cannabis event listing, The Maze Calendar.

To register for the event, visit https://www.cannabisrealestatesummit.com.

About Mannada Events

Mannada Events is a minority women-owned and -led cannabis event production company based in New York City. Mannada Events focuses on education and connection by bringing people together to learn about the cannabis industry from subject matter experts and each other. 

 

Event Contact

Kristin Jordan

Mannada

kristin@mannadaevents.com 

 

Media Contact

Leland Radovanovic

Conscious Communications Collective 

Leland@ConsciousComs.com

845-200-5249

 


AxisWireMarch 10, 2021
logo_cba.png?fit=850%2C531&ssl=1

5min1370

Cannabis Beverage Association (CBA) Partners With Leading Cannabis Industry Certification Company, TraceTrust, To Develop Standardized Industry Guidelines For The Cannabis Beverage Category

Sacramento, CA – March 9, 2021 – Today, the Cannabis Beverage Association (CBA), the leading trade association focused on the cannabis-infused beverages industry, announced its partnership with TraceTrust, the leading cannabis industry certification company.

The CBA was formed by cannabis industry leaders to unite and establish guidelines for the fastest growing segment in cannabis to ensure standards in manufacturing and consumer safety. Through industry leading best practices and policy reform, the CBA intends to revolutionize how cannabis is consumed.

With the mission to unite cannabis beverage stakeholders and advance the collective interests of the industry through advocacy and education, providing an alternative method of consuming cannabis in a socially acceptable manner with products that provide a safe and enjoyable experience for consumers, the CBA is dedicated to providing standards for the industry.

TraceTrust is committed to elevating the industry standard of dose accuracy to support cannabis edible manufacturers dedicated to product transparency and safety, furthering consumer confidence in cannabis products.

With an industry category estimated to be worth $1.85B in 2020 and having a 45% compound annual growth rate (according to Prohibition Partners), cannabis infused beverages are on track to become a major consumption method.

The CBA and TraceTrust have been working together over the last year to develop the partnership, so that they can identify the future needs for certification in the growing cannabis beverage industry.

“This partnership will allow us to establish best practices and set the standards for cannabis beverages testing, and TraceTrust is the most qualified to provide this certification.” said Macai Polansky, CBA President and Founder.

“The CBA is focused on doing the right things from the beginning and focusing on developing a standardization process is so important to do in a maturing industry.” said Merril Gilbert of TraceTrust.

The CBA looks to those in the beverage industry to band together to build a unified front to develop these standards.

About Cannabis Beverage Association

Founded in 2019 and headquartered in Sacramento, CA, the Cannabis Beverage Association (CBA) is a trade association established to represent and advocate on behalf of the producers and consumers of cannabis beverages. By educating policymakers and consumers, establishing standards for operators to uphold, and advocating for common-sense policies, we can ensure that the cannabis beverage industry delivers safe, high-quality, and reliable products to the consumers who enjoy them. For more information, please visit cannabisbeverageassociation.org.

About TraceTrust

TraceTrust was co-founded in 2016 by Merril Gilbert and Rhiannon Woo, who have over 25 years of experience in food safety and manufacturing. They transitioned their expertise to the Hemp and Cannabis industries and are now committed to elevating industry standards for dose accuracy, product transparency, and safety to further consumer conscience in Cannabis and Hemp products. A True Dose™ and HGMP™ are the first universal independent third-party certifications to validate ingredients, good manufacturing practices, instructions for use, and label claims. For more information, visit tracetrust.com

 

CBA Media Contact:

Cynthia Salarizadeh

cynthia@salarmediagroup.com

 


AxisWireOctober 13, 2020
Screen-Shot-2020-10-13-at-8.28.31-AM.png?fit=960%2C547&ssl=1

4min870

Stevie Awards For Women in Business and the Folio Awards Recognizes Debra Borchardt and Highlights Trustworthy Investigative Journalism

New York,  October 13, 2020 – Green Market Report, the center for trustworthy business, financial and economic news in the cannabis industry, and its Co-founder and Chief Executive Officer Debra Borchardt have been named the winners of the 17th annual Stevie Awards for Women in Business.

The Stevie Awards for Women in Business honor women executives, entrepreneurs, employees, and the companies they run– worldwide.  The Stevie Awards have been hailed as the world’s premier business awards. More than 1,500 entries were submitted this year for consideration in more than 100 categories as Green Market received the following awards:

Gold Stevie – Website of the Year: Green Market Report

Silver Stevie – Female Executive of the Year – Business Services: Debra Borchardt

“The Green Market Report website is an impressive website that does a great job of providing information about the cannabis industry including financial news, reports, and information about upcoming summits,” commented one of the judges. “Debra has built a successful media company reporting on a growing niche industry.”

In addition to the Stevie Awards, Green Market Report placed in the2020 Folio Awards, receiving an Honorable Mention in the Eddie Award For Investigative Journalism category. The winning story authored by Borchardt wasCovalent Collective Asks Investors For More Money. Folio Magazine provides publishers with the strategies, news, and insight they need to drive audience engagement and revenue growth. Folio’s Eddie & Ozzie Awards celebrate editorial and design excellence in the Publishing Community.

“It’s humbling and amazing to win these awards during such challenging times for media companies,” said Borchardt. “What a great way to celebrate our third year as a company. A new logo and new awards. It’s certainly an encouragement to continue to deliver great journalism”

About Green Market Report

The Green Market Report (GMR) is headquartered in New York with an office in Los Angeles. GMR is poised to be the center for trustworthy business, financial and economic news, and intelligence. The site offers coverage on financial matters including news briefs on business, cultivation, and extraction, cannabis company stock prices, and wholesale cannabis pricing. For more information, please visit www.greenmarketreport.com or email info@greenmarketreport.com. Follow us on Facebook, Instagram, and Twitter @GreenMarketRpt.

About the Stevie Awards

Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.

 

 


StaffOctober 1, 2020
zelira.jpg?fit=850%2C531&ssl=1

5min1341

Launches First-in-the-State Medical Cannabis Product 

Scientifically Formulated for Autism Patients of All Ages

NEW ORLEANS (LA) October 1, 2020 /AxisWire/ Louisiana-based Ilera Holistic Healthcare is pleased to announce the statewide launch of the HOPE™ line of medical cannabis tinctures based on groundbreaking scientific research on using cannabis to treat the symptoms of autism spectrum disorder (ASD) in both children and adults.

Grown, cultivated, processed and packaged in Louisiana through a partnership between Ilera Holistic and Southern University’s Agricultural Center, HOPE™ products are available exclusively through state-licensed MMJ pharmacies and available to all Louisiana patients and families through a doctor’s prescription. 

“After seeing the success of HOPE™ in Pennsylvania, we were determined to bring it to patients of Louisiana, a state where we exceed the national percentage of autism diagnoses–while at-risk and under-served patients still struggle to receive safe and effective healthcare,” says Ilera Holistic CEO Dr. Chanda Macias. “Louisiana families deserve full access to all the benefits that cannabis medicine can provide, and we are thrilled to have HOPE in this market and available to everyone.”

Scientific research shows cannabis to be safe and effective on patients (including children) to treat ASD, and patients who use it have reported significant improvement in quality of life, mood, and sleep–and less reliance on other medications. 

HOPE™ is the brainchild of Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education and advocacy of medical marijuana.

“The autism community in Louisiana is blessed to have a partner in Ilera Holistic Healthcare to bring HOPE to families affected by ASD,” says Daniels. “Now more than ever,  patients are struggling with the symptoms associated with autism. I am so thrilled that Ilera Holistic Healthcare is bringing HOPE to so many Louisiana patients who need it!”

“HOPE™ is another product with which we are proud to be associated,” said Janana Snowden, director of the Southern Institute for Medicinal Plants at the Southern University Agricultural Research and Extension Center. “The work we do aims to not only provide valuable research but to also provide potentially beneficial and accessible treatments for symptoms due to conditions that thousands of people live with daily, like autism.”

HOPE™ was formulated by Zelira Therapeutics, a leading global therapeutic medical cannabis company with access to the world’s largest and fastest growing cannabis markets. The company’s focus is on developing branded cannabis products for the treatment of a variety of medical conditions including insomnia, autism and chronic non-cancer pain.

HOPE™ is gluten, dairy, soy and nut-free; scientifically formulated, lab tested, and pesticide free; and only available in the state of Louisiana at licensed cannabis pharmacies. HOPE™ will be available in two formulations: “HOPE1,” a 1:1 THC:CBD tincture, and “HOPE2”, a 5:1 THC:CBD tincture. 

About Ilera Holistic Healthcare 

Ilera Holistic Healthcare is a fully integrated medical marijuana company that fuses science and innovation to discover life-changing therapies. In Louisiana, we partner our world-class cultivation and extraction methods with Southern University’s to expertly create and deliver consistent, high quality medicines. From seed and soil to dispensary shelves, Ilera is committed to providing a superior health and wellness experience. 

 

###

 


AxisWireAugust 18, 2020
logo_mydecine-2.png?fit=850%2C531&ssl=1

9min940

Being Facilitated Under a Schedule 1 Health Canada Dealer’s License

DENVER, Colorado, USA, August 18, 2020 /AxisWire/ Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine™” or the “Company”) is pleased to announce it is the first organization to exercise its cGMP(₁) capabilities under a special license to legally produce, transfer, sell, and export pharmaceutical-grade psilocybin, naturally derived from whole-mushroom extraction.

Under the coverage of a Health Canada Schedule 1 Controlled Drugs and Substances Dealer’s License, Mydecine™ has the full range of capabilities to extract fungi’s natural psychedelic compounds, such as psilocybin and psilocin from certain species of fruiting body mushrooms all the way through to distribution. Mydecine™ also has the ability to conduct the most advanced techniques to produce purified pharmaceutical-grade extract, then legally export its finished byproducts to its various research partners throughout the world, including but not limited to the Imperial College of London and Johns Hopkins University.

The Company is also capable of supporting commercial research institutions with product donations, including charitable contributions to provide its purified extracts and formulations to end-of-life distressed patients. The announcement comes on the heels of a recent landmark decision by Health Canada to permit four terminally ill patients to consume psilocybin mushrooms to ease their distress. This historic decision establishes a precedent that will pave the way for a wider adoption of psilocybin-based therapies.

“Mydecine’s breakthrough to legally supply naturally-sourced psilocybin within our spore-to-sale™ process will be a major advancement for mental therapeutics, due to the fact that these unique psychedelic compounds are both safe and effective for afflictions, such as depression, anxiety, and PTSD,” quoted Damon Michaels, COO and Co-Founder of Mydecine™.

There is still debate as to which is more successful in psychedelic-based treatments between naturally derived psilocybin or the use of a synthetic form. Given Mydecine’s full legal ability to access both types of active compounds, the Company is poised to internally answer that question as well as aid various qualified groups also conducting this type of research. In theory, there are a plethora of added benefits in regard to the entourage effect(₂) of naturally-sourced psilocybin versus the synthetic route. Additionally, Mydecine™ is developing a number of unique API’s(₃) from their naturally-sourced cGMP psychedelic extracts. Mydecine™ will also be conducting R&D to produce novel proprietary formulations by synergizing psychedelic fungi compounds with other various API’s; Mydecine™ will then attach their formulations to their exclusive delivery mechanisms. Mydecine™ plans to utilize these psychedelic medicinal formulations in various clinical environments around the world in aspiration to better the lives of many.

The Company notes that although several international companies and research institutions are permitted to utilize synthesized psilocybin, the process is extremely challenging and cost prohibitive(₄) with a single gram having the price tag of thousands of dollars. Being able to legally extract psilocybin from its natural source, Mydecine™ will hope to reduce these significant costs and improve the scalability of world-class research initiatives and novel therapies.

CEO and Director of Mydecine™, Joshua Bartch stated, “We are extremely grateful to have the ability to provide cGMP psychedelic API’s to qualified organizations, research partners, nonprofits, and clinical groups throughout the globe. We believe the reason current psilocybin-based research initiatives come with a very high cost using inefficiently produced synthetic psilocybin is simply due to a lack of capabilities and legal restraints. Mydecine’s legal capabilities through the dealer’s license will incorporate our range of abilities, which will be valuable for naturally-sourced medicine paired with new-age technology. We believe our achievement is the first-of-its-kind.”

1 Current Good Manufacturing Practices. GMP is a system for ensuring that products are consistently produced and controlled according to the best quality standards.

2The“entourage effect” is a proposed mechanism by which active compounds act synergistically to modulate the overall effects of multiple active compounds working together to produce a polypharmaceutical medicine.

3Active Pharmaceutical Ingredient/s are single or poly ingredients in pharmaceutical medicines that are biologically active.

4 Current synthesized psilocybin applied to recent psychedelic research sells for ~$7-10k USD per gram.

 

About Mydecine Innovations Group Inc.
Mydecine Innovations Group™is a publicly traded life sciences parent company with offices in Denver, CO and Vancouver, BC. Mydecine™ is dedicated to the development and production of adaptive pathway medicine, natural health products and digital health solutions stemming from fungi. Mydecine’s experienced cross functional teams have the dynamic capabilities to oversee all areas of medicine development, including synthesis, genetic research, import/export, delivery system design, clinical trial execution, through to product commercialization and distribution. By leveraging strategic partnerships with scientific, medical, military, and clinical organizations, Mydecine is positioned at the forefront of psychedelic medicine naturally derived from fungi, therapeutic solutions, and fungtional™ mushroom vitality products. Our portfolio of unified companies, including Mydecine Health Sciences™, Mindleap Health™, and NeuroPharm™ focus on providing innovative and effective options that can provide millions of people with a healthier quality of life.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company.Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including,without limitation, the availability and continuity of financing, the ability of the Company to adequately protect and enforce its intellectual property, the Company’s ability to bring its products to commercial production, continued growth of the global adaptive pathway medicine, natural health products and digital health industries, and the risks presented by the highly regulated and competitive market concerning the development, production, sale and use of the Company’s products. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. This news release does not constitute an offer of securities for sale in the United States. These securities have not and will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied upon.


AxisWireAugust 18, 2020
Screen-Shot-2020-08-18-at-10.22.20-AM.png?fit=946%2C616&ssl=1

5min1030

Founder Case Mandel moves to President and Chairman

Humboldt, CA – August 18, 2020 /AxisWire/ Boldt Runners Corp. (the “Company”), the exclusive licensee of Cannadips CBD, the Original Smokeless Dip Pouch with CBD, is pleased to announce the appointment of former Altria executive, Peter Diatelevi, as Chief Executive Officer.  Peter will assume day to day leadership of the Company and will also join the Company’s Board of Directors.

As Diatelevi takes his place as CEO, the Company’s co-founder Case Mandel will move into an operational role as President and will continue to lead product innovation within the organization.  Mandel has also been appointed Chairman of the Company’s Board of Directors and will continue to oversee the direction of the product and brand.

Diatelevi has over twenty years’ experience leading field sales and sales operations at Altria Group, Inc., the largest U.S. tobacco manufacturer.  During his time at Altria, Diatelevi has held various senior executive roles, including Vice President Region Sales and Vice President of Sales Operations. His responsibilities included customer service and supply chain logistics, trade marketing, sales analytics, sales infrastructure, and state and trade relations.  In addition, Diatelevi was instrumental in leading the strategic analysis and creation of Ste Michelle Wine Estates’ future operating plans.

“As a co-founder it is an honor to be at a stage in the business where you have the opportunity to hire someone with over 20 years of tobacco and CPG experience on a national scale,” said Mandel. “I am excited to hand off CEO duties to Peter and work alongside him as the President of the Boldt Runners.  Peter is the right person for the job, and I am confident in his ability to execute the plan and take this company to the next level.”

Skilled at evaluating organizational and operational efficacy, and implementing solutions that improve ROI, Diatelevi will be instrumental in helping the Company complete its $5 million Series A fundraising round, of which to date, the Company has raised $3 million. The funds will go toward hiring experienced CPG executive talent, enhancing in-house manufacturing, and executing the go to market strategy at both retail and online.

“I am honored to be leading the Boldt Runners Corporation and joining such an amazing team.  In this evolving product space, the Cannadips brand is off to a great start.  We are extremely fortunate to have outstanding partners that bring strong operational expertise and a true spirit of innovation.  I look forward to driving the future success of the Cannadips brand and technology platform.”

About Boldt Runners Corporation

The Boldt Runners Corporation is based in the heart of Humboldt County, California.  Boldt Runners manufacturers, markets and sells Cannadips CBD – the Original Smokeless Dip Pouch with CBD, which has been built on the same values of quality, craftsmanship, and innovation that have made the Humboldt County region world-famous.  Since 2016, Cannadips CBD has been paving the way to a full flavor experience for traditional dippers without tobacco or nicotine.  Cannadips CBD comes in five core flavors; American Spice, Natural Mint, Tangy Citrus, Tropical Mango, and Fresh Wintergreen and can be found in over 5,000 stores nationwide.  Cannadips CBD is on a growth trajectory and is poised to provide more fantastic flavor and form options for the traditional adult smokeless tobacco consumer looking for alternatives.  No tobacco, No nicotine, All flavor.   For further information please check out www.cannadipscbd.com.


AxisWireJuly 21, 2020
logo_mydecine.png?fit=850%2C531&ssl=1

7min690

Vancouver – July 21, 2020 /AxisWire/ Mydecine Innovations Group Inc. (CSE: MYCO) (OTCMKTS: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health Inc. ( “Mindleap” ) has signed an agreement dated July xx, 2020  with Brightmind (“Brightmind”) to launch a comprehensive meditation program on Mindleap’s advanced digital health platform. Under the terms of the agreement Brightmind will provide specialised meditation content to Mindleap and Mindleap will make that content available for purchase on the platform. 

Brightmind is a leading meditation app that provides customized and practical instruction by world-class meditation experts. Brightmind offers a robust curriculum that is based on an approach to teaching developed over the past 40 years by the esteemed meditation educator Shinzen Young

Brightmind is the first and only app that makes Shinzen’s powerful system easily available. The Brightmind app has been downloaded over 100,000 times and has been featured by Apple in their coveted “New Apps We Love” section, as well as Forbes and Huffington Post. Shinzen’s system is so clear and well organized that neuroscience researchers at Harvard and other top universities use his system to design their experiments and have brought Shinzen on as a research consultant.

Mindleap Founder and CEO Nikolai Vassev commented: “Our vision is for a world where people can make lasting life changes by having advanced tools and access to expert mental health professionals right from the palm of their hand. Mindfulness can have numerous benefits, everything from decreased stress and sadness to increased levels of happiness and focus. Brightmind’s programs have provided radical transformations for thousands of people and the partnership with Mindleap should lead to more value for our customers and platform. 

Over the past 20 years, meditation and mindfulness-based programs have become increasingly popular. Doctors and mental health professionals are embracing meditation because scientific studies are beginning to show that it works, particularly for stress-related conditions. 

The market for meditation apps has exploded into the mainstream and shows little sign of slowing down. In 2019 alone, the meditation market reached $1.2 Billion (USD). Employers are embracing mindfulness training and leading apps like Headspace and Calm are reaching over 50 million downloads while commanding billion dollar valuations. The major players offer relatively simple and shallow meditation instruction, which their users quickly exhaust while Brightmind’s comprehensive and proven programs offer a much more robust value to end users.  

Meditation, when practiced and contextualized well, is one of the most effective methods for improving mental health. 

Brightmind Founder and CEO Toby Sola commented: “Meditation is a way to upgrade our mental software to meet the demands of our rapidly changing world. We have been hard at work to deliver exceptional programs and are thrilled to collaborate with Mindleap so we can deliver our programs to even more people.” 

The Brightmind Meditation program will be a part of five other digital health programs that will be offered on Mindleap later this fall. The scalability, consistency, and reduced costs to end users create more comprehensive and versatile offering for the Mindleap platform. 

About Mydecine Innovations Group 

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. Mydecine’s experienced cross functional dynamic team has the capability to oversee all areas of drug development including synthesis, drug delivery system development, clinical trial execution, through to product commercialization and marketing. By leveraging strategic partnerships with scientific, medical, military, and clinical organizations Mydecine is at the forefront of the efficient development of psychedelic derived medicines and therapeutic solutions. Our trailblazing portfolio of companies is focused on providing innovative and effective treatment options that can help millions of people live healthier lives.

About Mindleap Health 

Mindleap is developing an advanced digital health platform that will provide support for people that are looking to achieve personal transformations and overcome mental health challenges. Mindleap is the only digital health platform that combines telehealth with mood, emotion and habit tracking. This is a paradigm shift to conventional mental health as Mindleap personalized support and users have the tools needed to track their progress and take control of their mental health.   

Learn about Mindleap Health 

About Brightmind 

Brightmind is a leading meditation application that presents a unique approach to meditation that users describe as comprehensive, precise, and practical. Brightmind helps people deepen their practice, learn how to meditate while doing daily activities and use meditation to fuel a positive vision for their lives. 

Download Brightmind today for free on the App Store or Google Play store.

 


AxisWireJuly 21, 2020
logo_papa.png?fit=850%2C531&ssl=1

5min1000

EUREKA, Calif. – July 21, 2020 – Papa & Barkley, the leading cannabis wellness company in California, best known for its award-winning topicals and tinctures, today announced the launch of its Releaf Gummies, a line of sugar-free, gluten-free, keto-friendly, zero-calorie, full spectrum, and solventless edibles. They come in four fruity flavors: Tart Apple and Berry Burst, which are vegan, and Juicy Orange and Wild Strawberry.   

Designed for health-conscious consumers, Releaf Gummies are Papa & Barkley’s first line of edible wellness products. Great for stress, anxiety, relaxation, sleep, and acute pain, each gummy contains 5mg of THC, making it easy for consumers to control and increase their dose as needed. 

According to Headset, a market data subsidiary of Nielsen, consumer demand for cannabis-infused gummies has surged in California since March, suggesting that consumers are purchasing more edibles due to concerns around respiratory health and COVID-19. During the ongoing pandemic, edibles has maintained its momentum as the top selling product category making up roughly 56% of legal cannabis sales in California during May this year.

Unlike the majority of gummies on the market, which are made with corn syrup, sugar, unnatural dyes and chemically-processed cannabis, Releaf Gummies are formulated with coconut oil infused solventless hash – the collection of ripe, cannabinoid-rich crystals of the cannabis plant. Papa & Barkley’s unique and proprietary chemical-free process maintains the full spectrum of the plant’s cannabinoids, terpenes and phytonutrients, resulting in a multi-dimensional, balanced mind and body sensation. Paired with clean and natural ingredients, Releaf Gummies are easily digestible and deliver a consistent effect. 

“Releaf Gummies are the only wellness gummies in California’s cannabis market designed for consumers with dietary preferences or restrictions, including athletes or individuals with health conditions that require a healthy diet,” said Papa & Barkley Co-Founder and Chief Products Officer, Guy Rocourt. “We partnered with Patricia Jones, the founder of Sistah’s Vegan, a black-owned business in our hometown of Eureka, to develop the vegan flavor profiles. From there, we created two additional fruit flavors using the same focus on health and clean ingredients.”

“As we grow, we remain committed to making clean and natural products that meet the health needs of our customers,” said Adam Grossman, Papa & Barkley Founder and CEO. “Our Releaf Gummies are addressing a gap in the market by providing consumers with delicious, sugar-free gummy options that, like all our products, are made without chemicals, are full spectrum, solventless, and use only natural ingredients.”

Each package of Papa & Barkley’s Releaf Gummies contains 100mg of cannabinoids in 20 gummies and costs $16. They are now available online and in dispensaries throughout California. To learn more, visit papaandbarkley.com/releafgummy/.

ABOUT PAPA & BARKLEY

Papa & Barkley™ is the leading cannabis wellness brand in California that creates highly effective, natural products that unlock the healing potential of the cannabis plant. All products are made using solventless, whole plant infusion processes with sun-grown cannabis and hemp flowers grown in the United States and produced in the company’s licensed, state-of-the-art manufacturing facilities.

Papa & Barkley was inspired by a son’s mission to ease his father’s debilitating back pain. Today the team is committed to caring for loved ones by producing safe, natural, and efficacious products using the whole plant. Papa & Barkley’s clean, chemical-free products are offered in THC-rich, CBD-rich, and Hemp CBD formulas, to address a variety of needs. 

Website: http://www.papaandbarkley.com 

Instagram: https://www.instagram.com/papaandbarkley 

Facebook: https://www.facebook.com/papaandbarkley 

 

MEDIA CONTACT

Sara Kern

Papa & Barkley

sara@papaandbarkley.com

 


Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

Thanksgiving is the day do their best work. How else can you eat all day unless you can maximize the munchies?

@GreenMarketRpt – 3 days

The Daily Hit: November 23, 2022

@GreenMarketRpt – 3 days

New York Cannabis Regulators Request Lifting of Retail Injunction

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.